A comprehensive study published in The Lancet Digital Health analyzed the efficacy and challenges of AI in clinical settings, revealing a critical need for real-world testing and diverse research methodologies to ensure AI’s reliable integration into healthcare.
After inking reverse merger, Graphite Bio divests gene editing pipeline to newly-formed biotech
Kamau Therapeutics has emerged from stealth mode after inking a deal with Graphite Bio for its genome editing assets. Kamau’s debut comes less than a
December 9, 2023